Aortic Repair Devices – Market Insights – Asia Pacific

The Asia Pacific market for aortic repair device market will expand rapidly over the forecast period, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent grafts. However, endovascular procedure volume growth will be hindered to some extent by a lack of physicians trained in endovascular techniques, limited awareness and screening of aneurysms, and limited by cost constrained healthcare facilities among few of the countries covered.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Asia Pacific from 2019 to 2033.

The endovascular treatment of aortic aneurysms will expand rapidly during the forecasted period.

In which indications will endovascular procedures experience the highest growth?

What impact will the increasing availability of branched and fenestrated endografts have on the competitive landscape in the coming years?

Which country will see the fastest growth of endovascular aortic repair procedures?

The aortic stent graft market is characterized by innovation, with companies launching products that enable the treatment of more complex aneurysms.

Which new products are entering the Asia Pacific market?

What impact will the launch of new stent grafts have on the competitive landscape?

Which indications will these products cover?

What impact will these products have on aortic surgical procedure volumes?

Treatment of aortic aneurysms is rising in the Asia Pacific countries due to improved healthcare infrastructure, contributing to procedure volumes.

Which segment of the aortic repair device market will see the greatest increase in procedure volumes through 2033?

For which indications will procedure volume growth be limited and which factors are limiting growth?

Which country will see the fastest procedure volume growth? which countries will see the slowest growth?

Aortic repair can be performed using endovascular, surgical, or hybrid procedures.

Which methods are preferred for which indications? How does this compare across the Asia Pacific countries?

What are the main drivers and limiters of growth in the endovascular device market?

For which indication will the growth of endovascular procedures be limited and why?

Which countries have the highest penetration of endovascular procedures?